Genomics Long-Term Trajectory Shines a Light on ARKG
July 10, 2020 at 11:40 AM EDT
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is already one of the best-performing healthcare ETFs over the past several years, but with a slew of secular tailwinds behind the genomics industry, ARKG’s best days could be ahead. Genomics companies try to better understand how...